Statement of Changes in Beneficial Ownership (4)
November 12 2019 - 11:27AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
WEIL JOHN D |
2. Issuer Name and Ticker or Trading Symbol
ALLIED HEALTHCARE PRODUCTS INC
[
AHPI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
|
|
(Last)
(First)
(Middle)
CLAYTON MANAGEMENT COMPANY, 4625 LINDELL BLVD., #335 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
11/7/2019 |
|
(Street)
ST LOUIS, MO 63108
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Common Stock | | | | | | | | 60520 (1) | I | Trust |
| Common Stock | | | | | | | | 90513 | D | |
| Common Stock | | | | | | | | 2500 | I | IRA |
| Common Stock | | | | | | | | 94427 (2) | I | Spouse |
| Common Stock | | | | | | | | 59101 (3) | I | Trust |
| Common Stock | | | | | | | | 7927 (4) | I | Corporation |
| Common Stock | | | | | | | | 137736 (5) | I | Limited Partnership |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Option to purchase common stock | $1.17 | 11/7/2019 | | A | | 750 | | 11/7/2020 | 11/7/2029 | Common stock | 750 | $0.00 (6) | 750 | D | |
| Option to purchase common stock | $2.13 | | | | | | | 11/8/2019 | 11/8/2028 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $2.22 | | | | | | | 11/9/2018 | 11/9/2027 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $2.26 | | | | | | | 11/10/2017 | 11/10/2026 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $2.34 | | | | | | | 11/12/2016 | 11/12/2025 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $3.16 | | | | | | | 11/13/2015 | 11/13/2024 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $4.62 | | | | | | | 11/14/2014 | 11/14/2023 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $5.18 | | | | | | | 11/8/2013 | 11/8/2022 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $7.10 | | | | | | | 11/10/2012 | 11/10/2021 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $8.68 | | | | | | | 11/11/2011 | 11/11/2020 | Common stock | 750 | | 750 | D | |
| Option to purchase common stock | $10.08 | | | | | | | 11/13/2010 | 11/13/2019 | Common stock | 750 | | 750 | D | |
| Explanation of Responses: |
| (1) | Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economical benefit in such shares. |
| (2) | The reporting person disclaims any economic benefit in such shares. |
| (3) | Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee. |
| (4) | Owned by a corporation controlled by the reporting person. |
| (5) | Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B). |
| (6) | Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
WEIL JOHN D
CLAYTON MANAGEMENT COMPANY
4625 LINDELL BLVD., #335
ST LOUIS, MO 63108 | X | X |
|
|
Signatures
|
| John D. Weil | | 11/11/2019 |
| **Signature of Reporting Person | Date |
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Apr 2023 to Apr 2024
